Literature DB >> 11430501

Antimicrobial resistance of Shigella sonnei in Korea during the last two decades.

J C Lee1, J Y Oh, K S Kim, Y W Jeong, J W Cho, J C Park, S Y Seol, D T Cho.   

Abstract

Eighty-eight strains of Shigella sonnei isolated in Korea during the period 1980 to 1999 were tested for susceptibility to 13 antimicrobial agents. S. sonnei isolates demonstrated high frequencies of resistance to sulfamethoxazole (97.7%), tetracycline (96.6%), and trimethoprim (95.5%). S. sonnei isolates from the 1990s were more resistant to nalidixic acid than isolates from the 1980s (100 vs 7.7%), while isolates from the 1990s were more susceptible to chloramphenicol than isolates from the 1980s (0 vs 100%). Ampicillin-resistant S. sonnei isolates produced the TEM-1 beta-lactamase with a pI of 5.4. The TEM-1 gene was located on conjugally transferable plasmids in the majority of isolates. S. sonnei isolates were all susceptible to cefotaxime, cefoxitin, ceftazidime, ciprofloxacin, and norfloxacin. These results indicate that cephalosporins and quinolones may be alternative antibiotics for the treatment of S. sonnei infections in Korea.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430501     DOI: 10.1034/j.1600-0463.2001.090307.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011.

Authors:  D Bhattacharya; H Bhattacharya; R Thamizhmani; D S Sayi; R Reesu; M Anwesh; C Kartick; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-29       Impact factor: 3.267

2.  Epidemiology of nalidixic acid resistance and TEM-1- and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000.

Authors:  Young Sook Jeong; Je Chul Lee; Hee Young Kang; Hak Sun Yu; Eun Young Lee; Chul Hee Choi; Seong Ho Tae; Yoo Chul Lee; Dong Taek Cho; Sung Yong Seol
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

3.  Changes in patterns of antimicrobial susceptibility and integron carriage among Shigella sonnei isolates from southwestern Korea during epidemic periods.

Authors:  Jae Young Oh; Hak Sun Yu; Sung Ki Kim; Seong Yong Seol; Dong Taek Cho; Je Chul Lee
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

4.  Microbial load, prevalence and antibiograms of salmonella and Shigella in lettuce and green peppers.

Authors:  Biniam Guchi; Mogessie Ashenafi
Journal:  Ethiop J Health Sci       Date:  2010-03

5.  Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran.

Authors:  Reza Ranjbar; Mohammad M Soltan Dallal; Malihe Talebi; Mohammad R Pourshafie
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

6.  Increasing clinical resistance rate of Shigella sonnei to cefotaxime in Jiangsu Province, China, between 2012 and 2015.

Authors:  Huimin Qian; Guoye Liu; Yin Chen; Ping Ma; Xiaoxiao Kong; Lu Zhou; Jie Hong; Changjun Bao; Bing Gu
Journal:  Ann Transl Med       Date:  2018-06

7.  Isolation and antibiotic susceptibility of Shigella species from stool samples among hospitalized children in Abadan, Iran.

Authors:  Nabi Jomezadeh; Shahram Babamoradi; Enayatollah Kalantar; Hazhir Javaherizadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

8.  The Epidemiological Influence of Climatic Factors on Shigellosis Incidence Rates in Korea.

Authors:  Yeong-Jun Song; Hae-Kwan Cheong; Myung Ki; Ji-Yeon Shin; Seung-Sik Hwang; Mira Park; Moran Ki; Jiseun Lim
Journal:  Int J Environ Res Public Health       Date:  2018-10-10       Impact factor: 3.390

Review 9.  History and Epidemiology of Bacillary Dysentery in Korea: from Korean War to 2017.

Authors:  Hyunjoo Pai
Journal:  Infect Chemother       Date:  2020-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.